• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SARS-CoV-2 刺突蛋白上的多个位点易受组织蛋白酶 B、K、L、S 和 V 的蛋白水解作用影响。

Multiple sites on SARS-CoV-2 spike protein are susceptible to proteolysis by cathepsins B, K, L, S, and V.

机构信息

Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology & Emory University, Atlanta, Georgia, USA.

Biomedical Engineering, Peking University, Beijing, China.

出版信息

Protein Sci. 2021 Jun;30(6):1131-1143. doi: 10.1002/pro.4073. Epub 2021 Apr 15.

DOI:10.1002/pro.4073
PMID:33786919
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8138523/
Abstract

SARS-CoV-2 is the coronavirus responsible for the COVID-19 pandemic. Proteases are central to the infection process of SARS-CoV-2. Cleavage of the spike protein on the virus's capsid causes the conformational change that leads to membrane fusion and viral entry into the target cell. Since inhibition of one protease, even the dominant protease like TMPRSS2, may not be sufficient to block SARS-CoV-2 entry into cells, other proteases that may play an activating role and hydrolyze the spike protein must be identified. We identified amino acid sequences in all regions of spike protein, including the S1/S2 region critical for activation and viral entry, that are susceptible to cleavage by furin and cathepsins B, K, L, S, and V using PACMANS, a computational platform that identifies and ranks preferred sites of proteolytic cleavage on substrates, and verified with molecular docking analysis and immunoblotting to determine if binding of these proteases can occur on the spike protein that were identified as possible cleavage sites. Together, this study highlights cathepsins B, K, L, S, and V for consideration in SARS-CoV-2 infection and presents methodologies by which other proteases can be screened to determine a role in viral entry. This highlights additional proteases to be considered in COVID-19 studies, particularly regarding exacerbated damage in inflammatory preconditions where these proteases are generally upregulated.

摘要

SARS-CoV-2 是导致 COVID-19 大流行的冠状病毒。蛋白酶在 SARS-CoV-2 的感染过程中起着核心作用。病毒衣壳上的刺突蛋白的切割导致构象变化,从而导致膜融合和病毒进入靶细胞。由于抑制一种蛋白酶,即使是像 TMPRSS2 这样的主要蛋白酶,也可能不足以阻止 SARS-CoV-2 进入细胞,因此必须确定可能发挥激活作用并水解刺突蛋白的其他蛋白酶。我们使用 PACMANS(一种识别和对底物的蛋白水解切割优先位点进行排序的计算平台)鉴定了刺突蛋白所有区域(包括对激活和病毒进入至关重要的 S1/S2 区域)中的氨基酸序列,这些区域易受弗林和组织蛋白酶 B、K、L、S 和 V 的切割,并用分子对接分析和免疫印迹验证,以确定这些蛋白酶是否可以结合在鉴定为可能切割位点的刺突蛋白上。总之,这项研究强调了组织蛋白酶 B、K、L、S 和 V 可用于考虑 SARS-CoV-2 感染,并提出了筛选其他蛋白酶以确定其在病毒进入中的作用的方法。这突出了 COVID-19 研究中要考虑的其他蛋白酶,特别是在这些蛋白酶通常上调的炎症前条件下,加剧了损伤的情况下。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e126/8138523/8aa6de071b6a/PRO-30-1131-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e126/8138523/f7f0bff491c8/PRO-30-1131-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e126/8138523/4e93e55434b0/PRO-30-1131-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e126/8138523/09fcf9b6b74d/PRO-30-1131-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e126/8138523/45daaf00a25f/PRO-30-1131-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e126/8138523/a5e289a16e1e/PRO-30-1131-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e126/8138523/6b93026b2afe/PRO-30-1131-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e126/8138523/8aa6de071b6a/PRO-30-1131-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e126/8138523/f7f0bff491c8/PRO-30-1131-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e126/8138523/4e93e55434b0/PRO-30-1131-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e126/8138523/09fcf9b6b74d/PRO-30-1131-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e126/8138523/45daaf00a25f/PRO-30-1131-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e126/8138523/a5e289a16e1e/PRO-30-1131-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e126/8138523/6b93026b2afe/PRO-30-1131-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e126/8138523/8aa6de071b6a/PRO-30-1131-g007.jpg

相似文献

1
Multiple sites on SARS-CoV-2 spike protein are susceptible to proteolysis by cathepsins B, K, L, S, and V.SARS-CoV-2 刺突蛋白上的多个位点易受组织蛋白酶 B、K、L、S 和 V 的蛋白水解作用影响。
Protein Sci. 2021 Jun;30(6):1131-1143. doi: 10.1002/pro.4073. Epub 2021 Apr 15.
2
Genome-wide bioinformatics analysis of human protease capacity for proteolytic cleavage of the SARS-CoV-2 spike glycoprotein.对人类蛋白酶对 SARS-CoV-2 刺突糖蛋白进行蛋白水解切割的能力进行全基因组生物信息学分析。
Microbiol Spectr. 2024 Feb 6;12(2):e0353023. doi: 10.1128/spectrum.03530-23. Epub 2024 Jan 8.
3
A Feasible Alternative Strategy Targeting Furin Disrupts SARS-CoV-2 Infection Cycle.针对弗林蛋白酶的可行替代策略可破坏 SARS-CoV-2 感染周期。
Microbiol Spectr. 2022 Feb 23;10(1):e0236421. doi: 10.1128/spectrum.02364-21. Epub 2022 Feb 9.
4
SARS-CoV-2 S protein:ACE2 interaction reveals novel allosteric targets.SARS-CoV-2 S 蛋白:ACE2 相互作用揭示了新的变构靶标。
Elife. 2021 Feb 8;10:e63646. doi: 10.7554/eLife.63646.
5
SARS-CoV-2 Spike Furin Cleavage Site and S2' Basic Residues Modulate the Entry Process in a Host Cell-Dependent Manner.SARS-CoV-2 刺突蛋白的弗林蛋白酶裂解位点和 S2'碱性残基以宿主细胞依赖的方式调节进入过程。
J Virol. 2022 Jul 13;96(13):e0047422. doi: 10.1128/jvi.00474-22. Epub 2022 Jun 9.
6
The Polybasic Cleavage Site in SARS-CoV-2 Spike Modulates Viral Sensitivity to Type I Interferon and IFITM2.SARS-CoV-2 刺突蛋白中的多碱性切割位点调节病毒对 I 型干扰素和 IFITM2 的敏感性。
J Virol. 2021 Apr 12;95(9). doi: 10.1128/JVI.02422-20.
7
A substrate for a cell free in vitro assay system to screen drugs targeting trypsin like protease-based cleavage of SARS-CoV-2 spike glycoprotein and viral entry.用于筛选针对 SARS-CoV-2 刺突糖蛋白基于胰蛋白酶样蛋白酶切割和病毒进入的药物的无细胞体外测定系统的底物。
J Med Virol. 2023 May;95(5):e28796. doi: 10.1002/jmv.28796.
8
The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets.SARS-CoV-2 刺突蛋白中的弗林裂解位点是在雪貂中传播所必需的。
Nat Microbiol. 2021 Jul;6(7):899-909. doi: 10.1038/s41564-021-00908-w. Epub 2021 Apr 27.
9
Proteolytic Activation of SARS-CoV-2 Spike at the S1/S2 Boundary: Potential Role of Proteases beyond Furin.SARS-CoV-2 刺突蛋白在 S1/S2 边界处的蛋白水解激活:除弗林蛋白酶以外的蛋白酶的潜在作用。
ACS Infect Dis. 2021 Feb 12;7(2):264-272. doi: 10.1021/acsinfecdis.0c00701. Epub 2021 Jan 12.
10
The SARS-CoV-2 and other human coronavirus spike proteins are fine-tuned towards temperature and proteases of the human airways.SARS-CoV-2 和其他人类冠状病毒的刺突蛋白针对人类气道的温度和蛋白酶进行了微调。
PLoS Pathog. 2021 Apr 22;17(4):e1009500. doi: 10.1371/journal.ppat.1009500. eCollection 2021 Apr.

引用本文的文献

1
The HDL-transporting scavenger receptor B1 promotes viral infection through endolysosomal acidification.转运高密度脂蛋白的清道夫受体B1通过内溶酶体酸化促进病毒感染。
iScience. 2025 Apr 24;28(6):112501. doi: 10.1016/j.isci.2025.112501. eCollection 2025 Jun 20.
2
Host transcriptome response to Mycoplasma bovis and bovine viral diarrhea virus in bovine tissues.宿主转录组对牛组织中牛支原体和牛病毒性腹泻病毒的反应。
BMC Genomics. 2025 Apr 10;26(1):361. doi: 10.1186/s12864-025-11549-2.
3
Role of N-linked glycosylation sites in human ACE2 in SARS-CoV-2 and hCoV-NL63 infection.

本文引用的文献

1
SARS-CoV-2 infection of human iPSC-derived cardiac cells reflects cytopathic features in hearts of patients with COVID-19.SARS-CoV-2 感染人类诱导多能干细胞来源的心肌细胞反映了 COVID-19 患者心脏中的细胞病变特征。
Sci Transl Med. 2021 Apr 21;13(590). doi: 10.1126/scitranslmed.abf7872. Epub 2021 Mar 15.
2
Spike mutation D614G alters SARS-CoV-2 fitness.刺突突变 D614G 改变了 SARS-CoV-2 的适应性。
Nature. 2021 Apr;592(7852):116-121. doi: 10.1038/s41586-020-2895-3. Epub 2020 Oct 26.
3
COVID-19: In the Eye of the Cytokine Storm.COVID-19:细胞因子风暴眼中的新冠病毒。
N-连接糖基化位点在人血管紧张素转换酶2(ACE2)在严重急性呼吸综合征冠状病毒2(SARS-CoV-2)和人冠状病毒NL63(hCoV-NL63)感染中的作用
J Virol. 2025 May 20;99(5):e0220224. doi: 10.1128/jvi.02202-24. Epub 2025 Mar 28.
4
Cathepsins in cellular entry of human pathogenic viruses.组织蛋白酶在人类致病病毒的细胞进入过程中的作用
J Virol. 2025 Apr 15;99(4):e0164224. doi: 10.1128/jvi.01642-24. Epub 2025 Mar 26.
5
Nucleocapsid Protein of SARS-CoV-2 Upregulates RANTES Expression in A172 Glioblastoma Cells.严重急性呼吸综合征冠状病毒2的核衣壳蛋白上调A172胶质母细胞瘤细胞中RANTES的表达。
Molecules. 2025 Feb 26;30(5):1066. doi: 10.3390/molecules30051066.
6
Aprotinin (I): Understanding the Role of Host Proteases in COVID-19 and the Importance of Pharmacologically Regulating Their Function.抑肽酶(I):了解宿主蛋白酶在 COVID-19 中的作用及药理调节其功能的重要性。
Int J Mol Sci. 2024 Jul 10;25(14):7553. doi: 10.3390/ijms25147553.
7
Aprotinin (II): Inhalational Administration for the Treatment of COVID-19 and Other Viral Conditions.抑肽酶(II):用于治疗 COVID-19 和其他病毒病的吸入式给药。
Int J Mol Sci. 2024 Jun 29;25(13):7209. doi: 10.3390/ijms25137209.
8
A novel multitargeted self-assembling peptide-siRNA complex for simultaneous inhibition of SARS-CoV-2-host cell interaction and replication.一种新型多靶点自组装肽-siRNA复合物,用于同时抑制SARS-CoV-2与宿主细胞的相互作用和复制。
Mol Ther Nucleic Acids. 2024 May 24;35(3):102227. doi: 10.1016/j.omtn.2024.102227. eCollection 2024 Sep 10.
9
Host Cell Proteases Involved in Human Respiratory Viral Infections and Their Inhibitors: A Review.宿主细胞蛋白酶在人类呼吸道病毒感染中的作用及其抑制剂:综述。
Viruses. 2024 Jun 19;16(6):984. doi: 10.3390/v16060984.
10
Influenza vaccination as a prognostic factor of humoral IgA responses to SARS-CoV-2 infection.流感疫苗接种作为体液IgA对严重急性呼吸综合征冠状病毒2感染反应的一个预后因素。
Cent Eur J Immunol. 2024;49(1):11-18. doi: 10.5114/ceji.2024.135462. Epub 2024 Feb 17.
Front Immunol. 2020 Sep 24;11:558898. doi: 10.3389/fimmu.2020.558898. eCollection 2020.
4
SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes.SARS-CoV-2 感染并诱导人心肌细胞产生细胞毒性作用。
Cardiovasc Res. 2020 Dec 1;116(14):2207-2215. doi: 10.1093/cvr/cvaa267.
5
Potential protease inhibitors and their combinations to block SARS-CoV-2.潜在的蛋白酶抑制剂及其组合来阻断 SARS-CoV-2。
J Biomol Struct Dyn. 2022 Feb;40(2):903-917. doi: 10.1080/07391102.2020.1819881. Epub 2020 Sep 14.
6
Anticipating the long-term cardiovascular effects of COVID-19.预测新型冠状病毒肺炎的长期心血管影响。
J Thromb Thrombolysis. 2020 Oct;50(3):512-524. doi: 10.1007/s11239-020-02266-6.
7
Cathepsin K: The Action in and Beyond Bone.组织蛋白酶K:在骨骼内外的作用
Front Cell Dev Biol. 2020 Jun 4;8:433. doi: 10.3389/fcell.2020.00433. eCollection 2020.
8
Inhibitors of SARS-CoV-2 Entry: Current and Future Opportunities.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)进入抑制剂:现状与未来机遇
J Med Chem. 2020 Nov 12;63(21):12256-12274. doi: 10.1021/acs.jmedchem.0c00502. Epub 2020 Jun 25.
9
Cathepsin L-selective inhibitors: A potentially promising treatment for COVID-19 patients.组织蛋白酶 L 选择性抑制剂:COVID-19 患者的一种有前途的治疗方法。
Pharmacol Ther. 2020 Sep;213:107587. doi: 10.1016/j.pharmthera.2020.107587. Epub 2020 May 26.
10
Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts.人心脏中假定的新型冠状病毒受体血管紧张素转换酶2的细胞类型特异性表达。
Eur Heart J. 2020 May 14;41(19):1804-1806. doi: 10.1093/eurheartj/ehaa311.